BSE filing, NSE: SANDUPHQ. Summary written from the filing by ALFA Finder's alert engine.
Sandu Pharmaceuticals Ltd: key numbers
- Share price
- ₹35.95
- Market cap
- ₹34.73 Cr
- Revenue (annual)
- ₹69.93 Cr
- Net profit (annual)
- ₹1.77 Cr
- P/E (TTM)
- 14.3×Sector 45.9×
- Promoter holding
- 37.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandu Pharmaceuticals Ltd
All →Sandu Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals intimated that Non-Executive Independent Director Dr Neeti Madan Kapre has changed her name to Dr Neeti Gupta after marriage. The DIN, designation and directorship remain unchanged.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals Limited has issued a reminder to physical shareholders regarding the mandatory submission of PAN and KYC details. This compliance follow-up aims to facilitate electronic dividend payments.
Sandu Pharmaceuticals Management Change
Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals has appointed M/s. Dave & Dave as Statutory Auditors for a five-year term, following the tenure expiry of the previous auditors.
Sandu Pharmaceuticals Annual General Meeting
Sandu Pharmaceuticals Limited held its 41st Annual General Meeting on September 11, 2026, via video conferencing to transact ordinary and special business items.
Other board meeting date announcements
All →Bajaj Steel Industries Board Meeting Date
Bajaj Steel will hold a board meeting on 6 November 2026 to approve unaudited quarterly and half-year results. The trading window stays closed.
Aashka Hospitals Board Meeting Date
Aashka Hospitals Ltd informed BSE of a board meeting on 05 November 2026 to consider unaudited standalone financial results for the half year ended September 30, 2026. The filing is a routine board meeting intimation.
ECS Biztech Board Meeting Date
ECS Biztech schedules a 4 November 2026 board meeting to approve September 2026 quarter and half-year standalone results. Trading window stays closed until 48 hours post-results.
Orchasp Board Meeting Date
Orchasp will hold a board meeting on November 11, 2026 to approve unaudited half-yearly results. The trading window stays closed until November 13, 2026.
Vintage Securities Board Meeting Date
Vintage Securities will hold a board meeting on 05 November 2026 to consider unaudited standalone half-yearly results for September 2026. The meeting date is advance notice and the trading window closes from 01 October 2026.
SVP Global Textiles Board Meeting Date
SVP Global Textiles schedules a 9 November 2026 board meeting to consider September 2026 quarter results. Trading window stays closed until 48 hours after results.